Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Tuesday, September 20, 2016

The AAN (American Academy of Neurology) seeks comments from MS Patients and Caregivers


                                                                  
  

Click here to receive MS news via e-mail

The information found below 


This update to the AAN’s 2002 published guideline on disease modifying therapies (DMTs) for MS reviews the evidence and provides recommendation statements regarding starting, switching, and stopping DMTs for MS.

The AAN seeks comments on the following issues:


Interpretation and inclusion of evidence




Clarity and comprehensiveness of conclusion statements




Clarity and comprehensiveness of recommendations




Comprehensiveness of the document







Comment Period Closes October 8, 2016

The AAN is committed to developing guidelines and evidence-based documents that incorporate patient and caregiver perspectives in a meaningful way. 

In addition to the draft manuscript of the full guideline provided for review, there is an accompanying summary version for lay stakeholders, such as patients, caregivers, and advocates, who wish to provide feedback.

This guideline manuscript draft and accompanying public summary are made available at this time only for the purpose of obtaining comments from professionals and public stakeholders. Because these documents are not in their final, publishable form, we ask that you maintain discretion by refraining from publishing, posting, disseminating, or otherwise releasing the contents of these documents until further notice is received from the AAN.


Click the link showing above, to comment


MS Views and News
Providing educational information, resources and services for those affected by MS

No comments: